Baby

Widower Alleges Johnson & Johnson Concealed Evidence of Baby Powder’s Cancer Risk

by

MIAMI (AP) — Johnson & Johnson is facing allegations that it ignored evidence linking its baby powder to ovarian cancer and continued to promote its safety. The pharmaceutical giant chose to “deny, deny, deny” the potential risks associated with its iconic product, according to an attorney representing the widower of a woman who died from ovarian cancer after using the powder. The case, which is scheduled to go to trial next week in Miami, Florida, raises significant questions about the ethical conduct of Johnson & Johnson and its marketing practices. The widower’s attorney argues that … Read more

MoDOT Director Denies Claim Unborn Baby Killed in Work Zone Crash Was State Employee

by

JEFFERSON CITY, Mo. – The director of the Missouri Department of Transportation (MoDOT) has recently faced backlash after his testimony regarding a fatal work zone crash in St. Louis County. The incident, which occurred several years ago, tragically claimed the lives of a pregnant highway worker and her unborn child. In court, MoDOT lawyers alleged that the unborn baby was a state employee, a claim that has been strongly denied by MoDOT’s director, Patrick McKenna. During a hearing with lawmakers, Rep. Jim Murphy expressed his concerns about the case, stating, “You had a worker who … Read more

Reckitt Benckiser Stock Plunges 15% as Jury Awards $60 Million in Damages Over Enfamil Baby Formula

by

BELLEVILLE, Ill. – Reckitt Benckiser Group Plc, a UK consumer goods company, experienced a sharp decline in stock prices following a court ruling that awarded $60 million in damages to an Illinois woman. The jury determined that the company’s Enfamil baby formula played a role in the death of her premature baby. This case marks the first of its kind to proceed to trial in the United States. The verdict caused a 15% drop in Reckitt Benckiser Group’s stock, resulting in the company’s lowest level in a decade. This decline wiped out approximately £5.4 billion … Read more

Abbott and Reckitt Benckiser Clash in Court: $60M Verdict Over Enfamil Baby Formula

by

NORTH CHICAGO, ILLINOIS – Abbott Laboratories saw a decline in its stock price on Friday following a jury verdict in an Illinois state court. The jury ordered rival company Reckitt Benckiser’s Mead Johnson unit to pay $60 million over allegations that a premature child died after consuming the company’s Enfamil baby formula. This verdict represents the first trial outcome among the hundreds of lawsuits filed against both Reckitt Benckiser and Abbott, all claiming that their baby formulas caused a gastrointestinal disease called necrotizing enterocolitis (NEC) in children. Abbott’s stock dropped approximately 4% after the news, … Read more